Compounds > vatalanib
Page last updated: 2024-09-04

vatalanib and sf 2370

vatalanib has been researched along with sf 2370 in 2 studies

Compound Research Comparison

Studies
(vatalanib)		Trials
(vatalanib)		Recent Studies (post-2010)
(vatalanib)		Studies
(sf 2370)		Trials
(sf 2370)		Recent Studies (post-2010) (sf 2370)
27642981805

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)sf 2370 (IC50)
Chain A, Serine/threonine-protein kinase pknBMycobacterium tuberculosis1
Serine/threonine-protein kinase D3Homo sapiens (human)0.25
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)0.145
High affinity nerve growth factor receptorHomo sapiens (human)0.0095
Protein kinase C gamma typeHomo sapiens (human)0.25
Protein kinase C alpha typeRattus norvegicus (Norway rat)0.125
Protein kinase C beta typeHomo sapiens (human)0.25
Protein kinase C delta typeRattus norvegicus (Norway rat)0.125
Protein kinase C epsilon typeRattus norvegicus (Norway rat)0.125
Protein kinase C zeta typeRattus norvegicus (Norway rat)0.125
Serine/threonine-protein kinase pim-1Homo sapiens (human)0.15
Cyclin-dependent kinase 4Homo sapiens (human)0.145
Phosphorylase b kinase gamma catalytic chain, liver/testis isoformHomo sapiens (human)0.0017
Protein kinase C alpha typeHomo sapiens (human)0.25
G1/S-specific cyclin-D1Homo sapiens (human)0.145
Protein kinase C eta typeHomo sapiens (human)0.25
G1/S-specific cyclin-E1Homo sapiens (human)0.145
Cyclin-dependent kinase 2Homo sapiens (human)0.145
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.043
Protein kinase C iota typeHomo sapiens (human)0.25
Phosphorylase b kinase regulatory subunit alpha, liver isoformHomo sapiens (human)0.0017
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoformHomo sapiens (human)0.0017
Protein kinase C gamma typeRattus norvegicus (Norway rat)0.24
Protein kinase C beta typeRattus norvegicus (Norway rat)0.125
Mitogen-activated protein kinase kinase kinase 9Homo sapiens (human)0.0267
Protein kinase C epsilon typeHomo sapiens (human)0.25
Mitogen-activated protein kinase kinase kinase 10Homo sapiens (human)0.0267
Protein kinase C theta typeHomo sapiens (human)0.39
Protein kinase C zeta typeHomo sapiens (human)0.25
Protein kinase C delta typeHomo sapiens (human)0.25
Serine/threonine-protein kinase D1Homo sapiens (human)0.25
Myosin light chain kinase, smooth muscleHomo sapiens (human)0.022
Mitogen-activated protein kinase kinase kinase 11Homo sapiens (human)0.0267
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoformHomo sapiens (human)0.0017
Protein kinase C eta typeRattus norvegicus (Norway rat)0.125
Phosphorylase b kinase regulatory subunit betaHomo sapiens (human)0.0017
Serine/threonine-protein kinase LMTK3Homo sapiens (human)0.0794
Protein kinase C theta typeRattus norvegicus (Norway rat)0.125

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Mazaideh, GM; Erdmann, F; Göllner, C; Rohe, A; Schmidt, M; Sippl, W; Wichapong, K1
Aiche, S; Bassermann, F; Becker, W; Canevari, G; Casale, E; Depaolini, SR; Ehrlich, HC; Felder, ER; Feuchtinger, A; Garz, AK; Gohlke, BO; Götze, K; Greif, PA; Hahne, H; Heinzlmeir, S; Helm, D; Huenges, J; Jeremias, I; Kayser, G; Klaeger, S; Koch, H; Koenig, PA; Kramer, K; Kuster, B; Médard, G; Meng, C; Petzoldt, S; Polzer, H; Preissner, R; Qiao, H; Reinecke, M; Reiter, K; Rueckert, L; Ruland, J; Ruprecht, B; Schlegl, J; Schmidt, T; Schneider, S; Schoof, M; Spiekermann, K; Tõnisson, N; Vick, B; Vooder, T; Walch, A; Wilhelm, M; Wu, Z; Zecha, J; Zolg, DP1

Other Studies

2 other study(ies) available for vatalanib and sf 2370

ArticleYear
Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay.
    European journal of medicinal chemistry, 2013, Volume: 61

    Topics: Dose-Response Relationship, Drug; Fluorescence Resonance Energy Transfer; Glycolipids; Humans; Membrane Proteins; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship

2013
The target landscape of clinical kinase drugs.
    Science (New York, N.Y.), 2017, 12-01, Volume: 358, Issue:6367

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Mice; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proteomics; Xenograft Model Antitumor Assays

2017